Department of Urology, University of Rochester Medical Center, Rochester, New York, USA.
J Endourol. 2022 Aug;36(8):1057-1062. doi: 10.1089/end.2021.0510.
Robot-assisted simple prostatectomy (RASP) has emerged as a safe surgical treatment for patients with benign prostatic hyperplasia with large glands (>80 mL). Several studies reported on perioperative outcomes of RASP by the standard multiport (MP) da Vinci robotic system approach. Studies conducted on RASP utilizing the novel single-port (SP) da Vinci SP robotic platform (Intuitive Surgical, Sunnyvale, CA) are scarce. We aimed to compare intraoperative and short-term postoperative outcomes between the da Vinci MP and SP robots for patients undergoing RASP in a referral center. In this retrospective study, we reviewed all patients who underwent RASP using MP or SP robot from September 2016 to March 2021. Intraoperative data, overall 30-day complications, complications by Clavien-Dindo classification, and 90-day readmission and reoperation rates were assessed and compared between the two groups using appropriate statistical methods. Seventy-five patients who underwent RASP were identified. Of these, 47 were in the MP group and 28 were in the SP. Compared with SP, mean operative time in MP group was 216.6 232.4 minutes ( = 0.39), estimated blood loss was 195.7 227.1 mL ( = 0.43), and length of stay was 2 2.5 days ( = 0.45). There was a trend toward higher overall complication rate in SP group MP (42.86% 21.28%, = 0.09). There were no significant differences in the readmission (17.02% 10.71%, = 0.52) and reoperation (2.1% 7.14%, = 0.34) rates between MP SP group. SP-RASP is safe and shows equivalent perioperative outcomes when compared with the MP robotic system. A marginal increase of complication rate was recorded in the SP group; however, this did not demonstrate statistical significance.
机器人辅助单纯前列腺切除术（RASP）已成为治疗大腺体（>80ml）良性前列腺增生患者的安全手术治疗方法。几项研究报告了标准多端口（MP）达芬奇机器人系统方法的 RASP 围手术期结果。利用新型单端口（SP）达芬奇 SP 机器人平台（直觉外科公司，加利福尼亚州森尼韦尔）进行的 RASP 研究很少。我们旨在比较转诊中心接受 RASP 的患者使用达芬奇 MP 和 SP 机器人的术中及短期术后结果。在这项回顾性研究中，我们回顾了 2016 年 9 月至 2021 年 3 月期间使用 MP 或 SP 机器人接受 RASP 的所有患者。使用适当的统计方法评估并比较了两组患者的术中数据、总体 30 天并发症、Clavien-Dindo 分类并发症以及 90 天再入院和再次手术率。确定了 75 名接受 RASP 的患者。其中，47 例为 MP 组，28 例为 SP 组。与 SP 相比，MP 组的平均手术时间为 216.6 232.4 分钟（ = 0.39），估计出血量为 195.7 227.1 mL（ = 0.43），住院时间为 2 2.5 天（ = 0.45）。SP 组的总体并发症发生率有升高的趋势，但无统计学意义（42.86% 21.28%， = 0.09）。MP 组和 SP 组的再入院率（17.02% 10.71%， = 0.52）和再次手术率（2.1% 7.14%， = 0.34）无显著差异。与 MP 机器人系统相比，SP-RASP 是安全的，并且具有相当的围手术期结果。SP 组记录到并发症发生率略有增加，但无统计学意义。
